Capital Flow Monitor · Sponsors · CIK 1991732
Cantai Therapeutics, Inc.
3675 MARKET STREET, PHILADELPIA, PA, 19104 · 603-996-1218
Biotechnology · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$3.0M
Sold
$3.0M
% sold
100.0%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-01-21 | D ·current | 506(b) | $3.0M | $3.0M | 100.0% | 3 | EDGAR ↗ |
| 2025-07-15 | D | 506(b) | $1.1M | $550K | 50.0% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Ross Leimberg — Executive Officer / Director, Philadelphia, PA
-
Errik B. Anderson — Executive Officer, Philadelphia, PA
2 other raises
- Human Biotech, Inc. $10.0M of $10.0M · 100.0%
- Alloy Therapeutics, Inc. $30.0M of $40.0M · 75.1%
- Getta Vemuri — Executive Officer / Director, Philadelphia, PA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.